Delivery Order SPE2DB20D3101-SPE2DB22FQVD7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,248.46 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM powder packets, a medication used for the treatment of hyperkalemia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.32, is a delivery order for the medication Veltassa 8.4 GM Powder Packet 30S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Veltassa 8.4 GM Powder Packets in quantities of 30 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $2,648.31 and an ultimate completion date of May 16, 2024. It is a firm fixed-price delivery order contract with no set-aside designation....
- This federal contract award, with a ceiling value of $18,009.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999 and running through November 2026. The contract provides for the delivery of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product, to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,456.26 Firm Fixed Price Delivery Order, awarded on December 9, 2024, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Veltassa 8.4 GM Powder Packet 30S. The $1,050.22 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 8, 2024 with a completion date of July 9, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $7,944.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. It is a delivery order contract with a firm fixed price of $2,943.52 and an ultimate completion date of October 15, 2024. The contract provides for the delivery of 4,566,083,356 units of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product, to support military treatment facilities and other federal healthcare programs....
- This federal contract award, valued at $10,763.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of Veltassa 16.8 GM Powder Packets, a pharmaceutical product used for medical treatment. This award does not have a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQVD7Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,624.23, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has a firm fixed price pricing type and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation. These IDCs, valued at up to $999,999,999.00 and $750,000 respectively, serve as primary vehicles for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those serving the military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/19/22 |